Overview of Assets
Our Assets give investors access to life sciences businesses with unique exposure across diverse modalities, therapeutic areas and geographies.
Our assets are largely maturing clinical development or commercial companies, nearing significant value inflection or realisation points, in which we hold meaningful stakes.
Our strategic objective is to support value creation in our investee companies.
We offer investors access to companies with compelling value propositions spanning innovation across multiple areas of healthcare. Our investee companies are at the forefront of cutting-edge technological advancement in their fields and have the required talent and technical expertise to deliver profound healthcare improvements to patients around the world.